Profil
D.
Lansing Taylor was the founder of Cellomics, Inc. (founded in 1996) where he held the title of Chairman & Chief Executive Officer.
He was also the founder of Acelerate, Inc. (founded in 2004) where he held the title of President & Chief Executive Officer.
Additionally, he founded Biological Detection Systems, Inc. Reagents Business in 2011 and Net Health Systems, Inc. in 1993 where he held the title of Director.
Dr. Taylor is also the founder of Cernostics, Inc., PredxBio, Inc., Biosystics, Inc., PLSG Capital Investment Programs, and Carnegie Mellon University.
Currently, Dr. Taylor is the Chairman of Biosystics, Inc., a Director at PLSG Capital Investment Programs, and a Professor at Carnegie Mellon University.
In the past, he served as the Chairman of Pittsburgh Life Sciences Green House in 2010, Director at Celsense, Inc., Senior Director at Vivisimo, Inc., Director at Sculptor Developmental Technologies, Inc., Manager at Thermo Fisher Scientific, Inc., and Principal at Pittsburgh Life Sciences Green House.
He also worked as a Vice President at Strategic Healthcare Group LLC from 2001 to 2004.
Dr. Taylor completed his undergraduate degree at Carnegie Mellon University in 1995 and received additional education at the University of Pittsburgh.
Aktive Positionen von D. Taylor
| Unternehmen | Position | Beginn |
|---|---|---|
PLSG Capital Investment Programs
 PLSG Capital Investment Programs Investment ManagersFinance Founded in 2002, PLSG Capital Investment Programs is a venture capital/private equity firm located in Pittsburgh, Pennsylvania. | Direktor/Vorstandsmitglied | - |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | Corporate Officer/Principal | - |
PredxBio, Inc.
 PredxBio, Inc. Medical/Nursing ServicesHealth Services SpIntellx, Inc. operates as a computational pathology company. It applies its proprietary artificial intelligence technologies to analyze whole slide image pathology samples based on spatial analytics. The company was founded by D. Lansing Taylor, S. Chakra Chennubhotla, Jeffrey L. Fine and Michael J. Becich and is headquartered in Pittsburgh, PA. | Gründer | - |
Biosystics, Inc.
 Biosystics, Inc. Data Processing ServicesTechnology Services Part of Numa Biosciences, Inc., Biosystics, Inc. provides a powerful analytical platform to efficiently turn experimental data into reproducible, actionable information and knowledge. The company is based in Pittsburgh, PA. The company's vision is to provide a "patient digital twins" platform containing computational models of patients derived from clinical data and patient-derived microphysiology systems for the advancement of precision medicine. The company's mission is to transform the rapidly evolving field of in vitro experimental models of disease and adme/tox ranging from traditional cell-based assays to organoids and structured microphysiology systems. The company offers two versions of the platform: academic and commercial, as well as a non-profit version. The CEO of the company is Mark Schurdak. | Vorsitzender | - |
Ehemalige bekannte Positionen von D. Taylor
| Unternehmen | Position | Ende |
|---|---|---|
Biological Detection Systems, Inc.Reagents Business
 Biological Detection Systems, Inc.Reagents Business Chemicals: AgriculturalProcess Industries Part of GE Healthcare Technologies, Inc., Biological Detection Systems, Inc.Reagents Business is an American company that manufactures cyanine molecule dyes. The company is located in the US. The company was founded by D. Lansing Taylor. Biological Detection Systems, Inc.Reagents Business was acquired by Amersham Plc /Old/ on June 01, 1995 for $6.51 million. | Gründer | - |
Pittsburgh Life Sciences Green House
 Pittsburgh Life Sciences Green House Investment ManagersFinance Pittsburgh Life Sciences Green House (PLSG) is a venture capital firm founded in 2002. The firm is headquartered in Pittsburgh, Pennsylvania. | Vorsitzender | 30.11.2010 |
Sculptor Developmental Technologies, Inc.
 Sculptor Developmental Technologies, Inc. Packaged SoftwareTechnology Services Part of Pfizer Inc., Sculptor Developmental Technologies, Inc. is a company that develops software. The company is based in Canonsburg, PA. Sculptor Developmental Technologies was acquired by Hospira, Inc., a subsidiary of Pfizer Inc. from St. Clair Hospital Corp. on April 30, 2008. | Direktor/Vorstandsmitglied | 30.04.2008 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | - |
Vivisimo, Inc.
 Vivisimo, Inc. Information Technology ServicesTechnology Services Vivisimo, Inc. developed and provided clustering and meta-search software solutions. The company was founded in 2000 and was headquartered in Pittsburgh, PA. | Corporate Officer/Principal | 28.02.2006 |
Ausbildung von D. Taylor
| Carnegie Mellon University | Undergraduate Degree |
| University of Pittsburgh | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| THERMO FISHER SCIENTIFIC | Health Technology |
| Private Unternehmen | 13 |
|---|---|
Cellomics, Inc.
 Cellomics, Inc. Medical SpecialtiesHealth Technology Cellomics, Inc. provides imaging technology products and services. It is a provider of technologies and products for the advancement of cell science research, including complete systems for high-content imaging of cells, tissues and whole organisms. The firm's platform includes automated imaging instruments, image analysis software, data management and bioinformatics software, coupled with reagents, cell-culture media, sera and specialty media formulations, along with laboratory automation and services. The company's offering is aimed at providing life science researchers with a quantitative, automated approach to understanding the biology of cells, including stem cells and cell systems, supporting all aspects of the drug discovery process as well as academic and systems biology research. Cellomics was founded on October 1996 and is headquartered in Pittsburgh, PA. | Health Technology |
PLSG Capital Investment Programs
PLSG Capital Investment Programs Investment ManagersFinance Founded in 2002, PLSG Capital Investment Programs is a venture capital/private equity firm located in Pittsburgh, Pennsylvania. | Finance |
Celsense, Inc.
 Celsense, Inc. Medical DistributorsDistribution Services Celsense, Inc. operates as a biotechnology company. It offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The firm’s products include Cell Sense and V-Sense. Its products are used in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. The company was founded by Eric T. Ahrens on July 12, 2005 and is headquartered in Pittsburgh, PA. | Distribution Services |
Net Health Systems, Inc.
 Net Health Systems, Inc. Packaged SoftwareTechnology Services Net Health Systems, Inc. engages in the provision of software solutions for healthcare professionals. It offers wound care services, revenue cycle services, digital marketing services, professional, and telehealth portal services. The company was founded in 1993 and is headquartered in Pittsburgh, PA. | Technology Services |
Pittsburgh Life Sciences Green House
Pittsburgh Life Sciences Green House Investment ManagersFinance Pittsburgh Life Sciences Green House (PLSG) is a venture capital firm founded in 2002. The firm is headquartered in Pittsburgh, Pennsylvania. | Finance |
Biological Detection Systems, Inc.Reagents Business
Biological Detection Systems, Inc.Reagents Business Chemicals: AgriculturalProcess Industries Part of GE Healthcare Technologies, Inc., Biological Detection Systems, Inc.Reagents Business is an American company that manufactures cyanine molecule dyes. The company is located in the US. The company was founded by D. Lansing Taylor. Biological Detection Systems, Inc.Reagents Business was acquired by Amersham Plc /Old/ on June 01, 1995 for $6.51 million. | Process Industries |
Acelerate, Inc.
 Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Strategic Healthcare Group LLC
 Strategic Healthcare Group LLC Miscellaneous Commercial ServicesCommercial Services Strategic Healthcare Group LLC was provided blood management consulting, education and informatics solutions. The company was headquartered in Indianapolis, IN. | Commercial Services |
Vivisimo, Inc.
Vivisimo, Inc. Information Technology ServicesTechnology Services Vivisimo, Inc. developed and provided clustering and meta-search software solutions. The company was founded in 2000 and was headquartered in Pittsburgh, PA. | Technology Services |
Sculptor Developmental Technologies, Inc.
Sculptor Developmental Technologies, Inc. Packaged SoftwareTechnology Services Part of Pfizer Inc., Sculptor Developmental Technologies, Inc. is a company that develops software. The company is based in Canonsburg, PA. Sculptor Developmental Technologies was acquired by Hospira, Inc., a subsidiary of Pfizer Inc. from St. Clair Hospital Corp. on April 30, 2008. | Technology Services |
Cernostics, Inc.
 Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Health Technology |
PredxBio, Inc.
PredxBio, Inc. Medical/Nursing ServicesHealth Services SpIntellx, Inc. operates as a computational pathology company. It applies its proprietary artificial intelligence technologies to analyze whole slide image pathology samples based on spatial analytics. The company was founded by D. Lansing Taylor, S. Chakra Chennubhotla, Jeffrey L. Fine and Michael J. Becich and is headquartered in Pittsburgh, PA. | Health Services |
Biosystics, Inc.
Biosystics, Inc. Data Processing ServicesTechnology Services Part of Numa Biosciences, Inc., Biosystics, Inc. provides a powerful analytical platform to efficiently turn experimental data into reproducible, actionable information and knowledge. The company is based in Pittsburgh, PA. The company's vision is to provide a "patient digital twins" platform containing computational models of patients derived from clinical data and patient-derived microphysiology systems for the advancement of precision medicine. The company's mission is to transform the rapidly evolving field of in vitro experimental models of disease and adme/tox ranging from traditional cell-based assays to organoids and structured microphysiology systems. The company offers two versions of the platform: academic and commercial, as well as a non-profit version. The CEO of the company is Mark Schurdak. | Technology Services |
